Related references
Note: Only part of the references are listed.Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping
Stefanie Dick et al.
BRITISH JOURNAL OF CANCER (2022)
Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study
Cristiana Banila et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
The DNA methylome of cervical cells can predict the presence of ovarian cancer
James E. Barrett et al.
NATURE COMMUNICATIONS (2022)
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples
James E. Barrett et al.
NATURE COMMUNICATIONS (2022)
In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers
Matti Lehtinen et al.
EXPERT REVIEW OF VACCINES (2022)
DNA methylation testing with S5 for triage of high-risk HPV positive women
Rachael Adcock et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/miR124-2 DNA Methylation (CONCERVE Study)
Wieke W. Kremer et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort
F. J. Vink et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Effective methylation triage of HPV positive women with abnormal cytology in a middle-income country
Arianis Tatiana Ramirez et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Methylation markersFAM19A4andmiR124-2as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study
Jesper Bonde et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Classification of high-grade cervical intraepithelial neoplasia by p16ink4a, Ki-67, HPV E4 and FAM19A4/miR124-2 methylation status demonstrates considerable heterogeneity with potential consequences for management
Frederique J. Vink et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018
Hannah G. Rosenblum et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial
Penelope Gray et al.
PLOS MEDICINE (2021)
Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia
Karolina Louvanto et al.
CLINICAL INFECTIOUS DISEASES (2020)
Methylation of HPV 16 and EPB41L3 in oral gargles: Associations with oropharyngeal cancer detection and tumor characteristics
Anna R. Giuliano et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study
Frederique J. Vink et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women
Karolina Louvanto et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Impact of HPV vaccination on cervical screening performance: a population-based cohort study
Jiayao Lei et al.
BRITISH JOURNAL OF CANCER (2020)
Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied
Simopekka Vanska et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomisedHPVvaccination trial with moderate coverage
Penelope Gray et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
HPV Vaccination and the Risk of Invasive Cervical Cancer
Jiayao Lei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)
Penelope Gray et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
Tim Palmer et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Long-term CIN3+risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis
Stefanie Dick et al.
GYNECOLOGIC ONCOLOGY (2019)
Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis
Helen Kelly et al.
BRITISH JOURNAL OF CANCER (2019)
Rarefaction, Alpha Diversity, and Statistics
Amy D. Willis
FRONTIERS IN MICROBIOLOGY (2019)
Distinct geographic clustering of oncogenic human papillomaviruses multiple infections in cervical cancers: Results from a worldwide cross-sectional study
Ville N. Pimenoff et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial
Darrel A. Cook et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Is the positive predictive value of high-grade cytology in predicting high-grade cervical disease falling due to HPV vaccination?
Farhana Sultana et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: A systematic review and meta-analysis
Sarah J. Bowden et al.
EBIOMEDICINE (2019)
Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up
Lise M. A. De Strooper et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III)
Matti Lehtinen et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Impact of HPV vaccination on outcome of cervical cytology screening in Denmark-A register-based cohort study
Lise Holst Thamsborg et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Molecular progression to cervical precancer, epigenetic switch or sequential model?
Belinda Nedjai et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Epigenome-based cancer risk prediction: rationale, opportunities and challenges
Martin Widschwendter et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
The Role of aDNA in Understanding the Coevolutionary Patterns of Human Sexually Transmitted Infections
Ville N. Pimenoff et al.
GENES (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer
Wina Verlaat et al.
EPIGENETICS (2018)
Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation
Annemiek Leeman et al.
GYNECOLOGIC ONCOLOGY (2018)
Transmission between Archaic and Modern Human Ancestors during the Evolution of the Oncogenic Human Papillomavirus 16
Ville N. Pimenoff et al.
MOLECULAR BIOLOGY AND EVOLUTION (2017)
Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer
Megan A. Clarke et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study
Kimberley Kavanagh et al.
LANCET INFECTIOUS DISEASES (2017)
Stochastic epigenetic outliers can define field defects in cancer
Andrew E. Teschendorff et al.
BMC BIOINFORMATICS (2016)
HPV immunisation and cervical screening-confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study
T. J. Palmer et al.
BRITISH JOURNAL OF CANCER (2016)
Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none
Mariam El-Zein et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer
Andrew E. Teschendorff et al.
NATURE COMMUNICATIONS (2016)
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution
Thomas E. Bartlett et al.
NATURE COMMUNICATIONS (2016)
HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and EPB41L3 methylation classifier
Adam R. Brentnall et al.
CANCER BIOMARKERS (2015)
Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial
Matti Lehtinen et al.
VACCINE (2015)
Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia
Julia M. L. Brotherton et al.
PAPILLOMAVIRUS RESEARCH (2015)
Methylation Analysis of the FAM19A4 Gene in Cervical Scrapes Is Highly Efficient in Detecting Cervical Carcinomas and Advanced CIN2/3 Lesions
Lise M. A. De Strooper et al.
CANCER PREVENTION RESEARCH (2014)
Vaccination: An evolutionary engine for pathogens? Conference report
B. Soubeyrand et al.
INFECTION GENETICS AND EVOLUTION (2014)
The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States
Harrell W. Chesson et al.
SEXUALLY TRANSMITTED DISEASES (2014)
Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions
Renske D. M. Steenbergen et al.
NATURE REVIEWS CANCER (2014)
CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease
Mariska Bierkens et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Evolutionary Ecology of Human Papillomavirus: Trade-offs, Coexistence, and Origins of High-Risk and Low-Risk Types
Paul A. Orlando et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Methylation of Human Papillomavirus Type 16 Genome and Risk of Cervical Precancer in a Costa Rican Population
Lisa Mirabello et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation
Andrew E. Teschendorff et al.
GENOME MEDICINE (2012)
Adverse Health Outcomes in Women Exposed In Utero to Diethylstilbestrol
Robert N. Hoover et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia
Matti Lehtinen et al.
SEXUALLY TRANSMITTED INFECTIONS (2011)
Is Smoking an Independent Risk Factor for Invasive Cervical Cancer? A Nested Case-Control Study Within Nordic Biobanks
Aline Simen Kapeu et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
The cell of origin of ovarian epithelial tumours
Louis Dubeau
LANCET ONCOLOGY (2008)
Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors
A Widschwendter et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
